Bioventus Inc Share Price

NASDAQ: BVS

Small Cap

$7.23

-0.05

(-0.69%)

as on September 13, 2025 at 1:29 am IST

$₹

Bioventus Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$7.07
Day's Price Range
$7.26
$7.23
2.21%
Downside
0.41%
Upside
52 Week's Low
52 Week's High
$5.81
52-Week Price Range
$14.38
$7.23
19.64%
Downside
98.89%
Upside

Bioventus Inc share price movements today

Previous Close: $7.28
Open: $7.17
Volume: 371.9K
Day's Low - High: $7.07 - $7.26
52 Week Low - High: $5.81 - $14.38

Bioventus Inc Historical Returns

1 Month Return: -3.98 %
3 Month Return: + 9.21 %
1 Year Return: -35.27 %
3 Year Return: -11.83 %
5 Year Return: 0 %

Bioventus Inc Stock Fundamentals & Key Indicators

Check Bioventus Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$487.0M

EPS (TTM)

0.6433

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

242.67

Industry PE ratio

-3.773885542168675

P/B Ratio

242.6667

PEG Ratio

2.1421

EBITDA

61.8M

Revenue (TTM)

564.1M

Profit Margin

0.33%

Return On Equity TTM

1.39%

Bioventus Inc Stock Valuation

Track how Bioventus Inc P/E has moved over time to understand its valuation trends.

Bioventus Inc in the last 5 years

Overview
Trends

Lowest (5.34x)

September 30, 2021

Industry (-3.77x)

September 13, 2025

Today (242.67x)

September 13, 2025

Highest (27.74x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 242.67x

Bioventus Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bioventus Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Bioventus Inc	BUY	$487.0M	NA	242.67	0.33%
Boston Scientific Corp.	BUY	$152.2B	154.93%	61.14	13.55%
Stryker Corporation	BUY	$146.6B	89.75%	50.77	12.25%
Abbott Laboratories	BUY	$232.8B	27.73%	16.78	32.43%
Medtronic Plc	BUY	$120.6B	-10.25%	25.98	13.63%

See all

Stock Returns calculator for Bioventus Inc Stock including INR - Dollar returns

The Bioventus Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Bioventus Inc investment value today

Current value as on today

₹69,866

Returns

₹30,134

(-30.13%)

Returns from Bioventus Inc Stock

₹35,273 (-35.27%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Bioventus Inc Stock

Based on 7 analysts

BUY

71.43%

Buy

14.29%

Hold

14.29%

Sell

Based on 7 analysts, 71.43% of analysts recommend a 'BUY' rating for Bioventus Inc. Average target price of $12.75

Bioventus Inc Share Price Target

Get share price movements and forecasts by analysts on Bioventus Inc.

What analysts predicted

43.29%UPSIDE

Target Price

$12.75

Current Price

$7.23

Analyzed by

7 Analysts

Target

$12.75

Bioventus Inc target price $12.75, a slight upside of 43.29% compared to current price of $7.23. According to 7 analysts rating.

Bioventus Inc Stock's Interest Amongst Investors

Search interest for Bioventus Inc Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 15, 2025 to September 14, 2025

Change:-36% versus previous 30 day period

Bioventus Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	119	137	120	135	129	151	138	153	123	147
Gross Profit	73	89	78	86	88	103	93	102	83	102
Operating Income	-92	6	2	1	5	-29	4	7	4	18
EBITDA	-73	20	15	14	17	-16	16	21	15	29
Interest Expense	9	10	10	10	10	9	9	8	7	7
Depreciation	16	14	13	12	11	13	12	12	11	12
Income Before Tax	-100	-4	-8	-8	-5	-39	-4	0	-3	10
Income Tax Expense	0	0	0	0	0	-7	0	0	0	1
Net Income	-139	-3	-7	-6	-4	-23	-4	0	-2	7
Net Profit Margin	-116.87%	-2.69%	-6.05%	-4.50%	-3.53%	-15.87%	-3.47%	-0.10%	-2.13%	5.05%

Bioventus Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	253	274	292	319	340	321	430	512	512	573
Gross Profit	179	183	199	235	249	233	302	331	328	388
Operating Income	-16	14	27	25	31	21	12	-167	-81	-11
EBITDA	15	44	59	54	61	52	45	-121	-23	-49
Interest Expense	14	15	18	19	21	9	1	12	40	38
Depreciation	-	-	-	29	30	28	34	66	73	49
Income Before Tax	-31	-5	8	6	9	15	9	-189	-121	-49
Income Tax Expense	2	1	0	1	1	1	-1	-44	0	-5
Net Income	-34	-17	-1	-12	6	16	19	-158	-156	-33
Net Profit Margin	-13.45%	-6.54%	-0.56%	-3.82%	2.01%	5.11%	4.50%	-30.99%	-30.49%	-5.85%

Bioventus Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	-8	-6	-4	-23	-5	0	-3	9
Operating Cash Flow	10	-8	10	-6	15	10	19	-19	25
Investing Cash Flow	33	-2	0	-1	0	0	24	0	-1
Financing Cash Flow	-62	8	0	-4	-7	0	-42	0	-14
Change in Cash	-17	-2	10	-11	6	11	-1	-18	10

Bioventus Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2014	Dec 2015	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-12	-34	4	8	14	9	-144	-121	-43
Operating Cash Flow	15	18	45	40	71	22	-13	15	38
Investing Cash Flow	-31	-60	-6	-7	-20	-283	-116	15	22
Financing Cash Flow	-6	31	-13	-10	-29	273	62	-26	-54
Change in Cash	-24	-10	25	21	22	12	-67	5	4

Global Institutional Holdings in Bioventus Inc

Funds	Holdings
Essex Woodlands Health Ventures	19.47%
Juniper Investment Co, LLC	10.37%
Nantahala Capital Management, LLC	6.17%
BlackRock Inc	4.23%
Vanguard Group Inc	3.82%

See all

Insights on Bioventus Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -2.63M → 7.45M (in $), with an average increase of 135.4% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 123.87M → 147.66M (in $), with an average increase of 16.1% per quarter
NO EFFECT
Against Peers
In the last 1 year, Boston Scientific Corp. has given 23.3% return, outperforming this stock by 58.6%
NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 144.2% return, outperforming this stock by 156.8%
NEGATIVE IMPACT
Price Dip
In the last 6 months, BVS stock has moved down by -24.8%

About Bioventus Inc

bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. bioventus accomplishes this with its orthobiologic products for musculoskeletal healing, regeneration and related biosurgery that engage and enhance the body’s natural healing processes. the company has two product portfolios for orthobiologics, bioventus active healing therapies and bioventus surgical, which are created through a combination of internal product development, product/business acquisition, and distribution agreements. established in 2012, bioventus is privately held and headquartered in durham, nc. the company has nearly 600 employees worldwide and its international headquarters is in hoofddorp, the netherlands. bioventus also has offices in memphis, tn, australia and canada, and a research and development site is located in boston. bioventus works with patients, payers and health care providers throughout the world, and generat

Organisation	Bioventus Inc
Headquarters	4721 Emperor Boulevard, Durham, NC, United States, 27703
Industry	Healthcare
CEO	Mr. Robert E. Claypoole
E-voting on shares	Click here to vote

Key Management of Bioventus Inc

Name	Title
Mr. Dave Venner	Senior VP & GM of Surgical
Mr. Robert E. Claypoole	President, CEO & Director
Mr. Mark L. Singleton	Senior VP & CFO
Mr. Anthony D'Adamio J.D.	Senior VP, General Counsel & Corporate Secretary
Mr. Mike Crowe B.S., M.B.A.	Senior Vice President of Operations
Mr. David Crawford	Vice President of Investor Relations & Treasurer
Ms. Katrina J. Church J.D.	Senior VP & Chief Compliance Officer
Ms. Helen Leupold	Senior VP & Chief Human Resources Officer

FAQs

What is Bioventus Inc share price today?

Bioventus Inc share price today is $7.23 as on September 13, 2025 at 1:29 am IST at the close of the market. Bioventus Inc share today touched a day high of $7.26 and a low of $7.07.

What is the 52 week high and 52 week low for Bioventus Inc share?

Bioventus Inc share touched a 52 week high of $14.38 on November 4, 2024 and a 52 week low of $5.81 on August 5, 2025. Bioventus Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $7.23,which is 49.72% down from its 52 week high and 24.44% up from its 52 week low.

What is Bioventus Inc's market capitalisation today?

Bioventus Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Bioventus Inc Stock (BVS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Bioventus Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bioventus Inc Shares that will get you 0.2075 shares as per Bioventus Inc share price of $7.23 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Bioventus Inc Stock (BVS) from India?

Indian investors can start investing in Bioventus Inc (BVS) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 7:36 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Bioventus Inc stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 7:36 am IST). Based on Bioventus Inc share’s latest price of $7.23 as on September 13, 2025 at 1:29 am IST, you will get 1.3831 shares of Bioventus Inc. Learn more about fractional shares .